D. Kleiner

Epidemiology · 2004–2023

A researcher in the Science corpus: 15 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom D. Kleiner trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. E. Brunt
  2. A. Sanyal

Who trusts D. Kleiner overall

  1. Z. Younossi
  2. Z. Goodman
  3. M. Rinella
  4. N. Chalasani
  5. E. Brunt
  6. C. Estes
  7. R. Loomba
  8. V. Ratziu
  9. Vincent Wai-Sun Wong
  10. Q. Anstee

Papers from D. Kleiner's perspective

Ordered by how strongly the researchers D. Kleiner trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Long‐term follow‐up of patients with NAFLD and elevated liver enzymes (Hepatology)
  2. ENDPOINTS AND CLINICAL TRIAL DESIGN FOR NONALCOHOLIC STEATOHEPATITIS (Hepatology)
  3. AGA technical review on nonalcoholic fatty liver disease. (Gastroenterology)
  4. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. (Gastroenterology)
  5. Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver‐related mortality (Hepatology)
  6. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. (American Journal of Physiology. Endocrinology and Metabolism)
  7. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. (Journal of Hepatology)
  8. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. (Journal of Hepatology)
  9. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings (Hepatology)
  10. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq (Science)

Their papers